Table 2.
Superficial capillary plexus | Deep capillary plexus | Choriocapillaris | |||||||
---|---|---|---|---|---|---|---|---|---|
Parameter | Control group | Amyloidosis group | p | Control group | Amyloidosis group | p | Control group | Amyloidosis group | p |
Mean ±SD | Mean ±SD | Mean ±SD | Mean ±SD | Mean ±SD | Mean ±SD | ||||
(95% CI) | (95% CI) | (95% CI) | (95% CI) | (95% CI) | (95% CI) | ||||
Central mVD (%) | 19.41 ± 1.61 (18.54–20.27) | 15.66 ± 3.59 (13.87–17.45) | <0.0001 | 28.45 ± 2.68 (27.02–29.88) | 23.45 ± 4.72 (21.10–25.80) | 0.0007 | 45.71 ± 5.08 (40.71–48.12) | 25.67 ± 4.33 (23.52–27.82) | 0.0005 |
Superior* (%) | 42.12 ± 3.67 (40.17–44.08) | 32.18 ± 7.16 (28.62–35.74) | <0.0001 | 43.98 (37.43–49.26) | 32.59 (17.05–45.49) | <0.0001 | 49.46 (44.47–52.49) | 40.66 (17.19–48.00) | <0.0001 |
Inferior* (%) | 43.24 ± 4.11 (41.05–45.43) | 31.85 ± 7.51 (28.12–35.59) | <0.0001 | 44.36 ± 3.36 (42.57–46.15) | 31.21 ± 9.57 (26.45–35.97) | <0.0001 | 51.38 (48.16–56.46) | 42.23 (16.48–51.02) | <0.0001 |
Nasal* (%) | 40.43 ± 3.45 (38.59–42.47) | 33.55 ± 5.34 (30.90–36.21) | <0.0001 | 43.42 ± 2.95 (41.85–44.99) | 33.74 ± 6.86 (30.33–37.15) | <0.0001 | 50.06 (45.40–55.21) | 42.88 (18.02–51.12) | <0.0001 |
Temporal* (%) | 40.70 ± 2.64 (39.29–42.11) | 33.13 ± 7.81 (29.25–37.02) | <0.0001 | 43.92 ± 2.30 (42.70–45.14) | 33.58 ± 8.33 (29.44–37.72) | <0.0001 | 50.38 (46.73–54.30) | 42.02 (17.80–52.02) | 0.0009 |
*Data presented as median (min to max).
*The comparisons were performed using the Brunner-Munzel test. Bold values indicate p value is statistically significant.